I(Ca(TTX)) channels are distinct from those generating the classical cardiac Na(+) current.
The Na(+) current component I(Ca(TTX)) is functionally distinct from the main body of Na(+) current, I(Na). It was proposed that I(Ca(TTX)) channels are I(Na) channels that were altered by bathing media containing Ca(2+), but no, or very little, Na(+). It is known that Na(+)-free conditions are not required to demonstrate I(Ca(TTX).) We show here that Ca(2+) is also not required. Whole-cell, tetrodotoxin-blockable currents from fresh adult rat ventricular cells in 65 mm Cs(+) and no Ca(2+) were compared to those in 3 mM Ca(2+) and no Cs(+) (i.e., I(Ca(TTX))). I(Ca(TTX)) parameters were shifted to more positive voltages than those for Cs(+). The Cs(+) conductance-voltage curve slope factor (mean, -4.68 mV; range, -3.63 to -5.72 mV, eight cells) is indistinguishable from that reported for I(Ca(TTX)) (mean, -4.49 mV; range, -3.95 to -5.49 mV). Cs(+) current and I(Ca(TTX)) time courses were superimposable after accounting for the voltage shift. Inactivation time constants as functions of potential for the Cs(+) current and I(Ca(TTX)) also superimposed after voltage shifting, as did the inactivation curves. Neither of the proposed conditions for conversion of I(Na) into I(Ca(TTX)) channels is required to demonstrate I(Ca(TTX)). Moreover, we find that cardiac Na(+) (H1) channels expressed heterologously in HEK 293 cells are not converted to I(Ca(TTX)) channels by Na(+)-free, Ca(2+)-containing bathing media. The gating properties of the Na(+) current through H1 and those of Ca(2+) current through H1 are identical. All observations are consistent with two non-interconvertable Na(+) channel populations: a larger that expresses little Ca(2+) permeability and a smaller that is appreciably Ca(2+)-permeable.
Chen-Izu
Y
Y
Department of Medicine, School of Medicine, University of Maryland, Baltimore, Maryland 21201, USA.
Sha
Q
Q
Shorofsky
S R
SR
Robinson
S W
SW
Wier
W G
WG
Goldman
L
L
Balke
C W
CW
D000818:Animals; D015220:Calcium Channels / Q000187:drug effects / Q000378:metabolism*; D002460:Cell Line / Q000166:cytology; D002462:Cell Membrane / Q000378:metabolism; D002586:Cesium / Q000037:antagonists & inhibitors* / Q000378:metabolism*; D004594:Electrophysiology / Q000379:methods; D006352:Heart Ventricles / Q000166:cytology; D006801:Humans; D008564:Membrane Potentials / Q000502:physiology; D009206:Myocardium / Q000166:cytology / Q000378:metabolism*; D051381:Rats; D017207:Rats, Sprague-Dawley; D017208:Rats, Wistar; D015222:Sodium Channels / Q000378:metabolism*; D013779:Tetrodotoxin / Q000494:pharmacology*; D014162:Transfection / Q000379:methods
D015220:Calcium Channels; D015222:Sodium Channels; D002586:Cesium; D013779:Tetrodotoxin